CIR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.326600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.352600E-01
Normal-vs-Stage2
4.030600E-01
Normal-vs-Stage3
4.776800E-01
Normal-vs-Stage4
4.912000E-01
Stage1-vs-Stage2
6.855400E-01
Stage1-vs-Stage3
6.797200E-01
Stage1-vs-Stage4
2.264800E-01
Stage2-vs-Stage3
7.928400E-01
Stage2-vs-Stage4
2.134500E-02
Stage3-vs-Stage4
2.255600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.865000E-01
Normal-vs-AfricanAmerican
2.982400E-01
Normal-vs-Asian
9.589600E-01
Caucasian-vs-AfricanAmerican
8.283600E-01
Caucasian-vs-Asian
3.901000E-01
AfricanAmerican-vs-Asian
4.628200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.440600E-01
Normal-vs-Female
5.482600E-01
Male-vs-Female
2.837000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.153580E-01
Normal-vs-Age(41-60Yrs)
7.773200E-01
Normal-vs-Age(61-80Yrs)
3.001200E-01
Normal-vs-Age(81-100Yrs)
3.198000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.356200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.489400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.871400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.460190E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.922600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.488000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.869830E-01
Normal-vs-Daily Drinker
2.530000E-01
Normal-vs-Weekly Drinker
3.472600E-01
Normal-vs-Occasional Drinker
9.922600E-01
Normal-vs-Social Drinker
2.762600E-01
Non Drinker-vs-Daily Drinker
5.525600E-01
Non Drinker-vs-Weekly Drinker
5.591400E-01
Non Drinker-vs-Occasional Drinker
1.589970E-02
Non Drinker-vs-Social Drinker
2.925800E-01
Daily Drinker-vs-Weekly Drinker
9.251200E-01
Daily Drinker-vs-Occasional Drinker
5.863500E-02
Daily Drinker-vs-Social Drinker
6.021600E-01
Weekly Drinker-vs-Occasional Drinker
1.346810E-01
Weekly Drinker-vs-Social Drinker
7.253400E-01
Occasional Drinker-vs-Social Drinker
1.447960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.890200E-02
Normal-vs-Grade 2
6.462500E-03
Normal-vs-Grade 3
3.059100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.704270E-02
Grade 1-vs-Grade 3
2.367600E-02
Grade 1-vs-Grade 4
2.890200E-02
Grade 2-vs-Grade 3
9.025600E-01
Grade 2-vs-Grade 4
6.462500E-03
Grade 3-vs-Grade 4
3.059100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.581040E-01
Normal-vs-NonDiabetic
4.263800E-01
Diabetic-vs-NonDiabetic
9.030500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.698180E-01
Normal-vs-NoPancreatitis
3.797600E-01
Pancreatitis-vs-NoPancreatitis
4.877200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.725800E-01
Normal-vs-N1
4.265400E-01
N0-vs-N1
7.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.223000E-01
Normal-vs-TP53-NonMutant
4.115400E-01
TP53-Mutant-vs-TP53-NonMutant
3.736400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
